Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 297

1.

Systemic Lupus Erythematosus Does Not Increase Risk of Adverse Events in the First 6 Months After Total Knee Arthroplasty.

Fein AW, Figgie CA, Dodds TR, Wright-Chisem J, Parks ML, Mandl LA, Su EP, Salmon JE, Mayman DJ, Lee YY, Figgie MP, Goodman SM.

J Clin Rheumatol. 2016 Oct;22(7):355-9. doi: 10.1097/RHU.0000000000000435.

PMID:
27660932
2.

Patients with Systemic Lupus Erythematosus Have Increased Risk of Short-term Adverse Events after Total Hip Arthroplasty.

Roberts JE, Mandl LA, Su EP, Mayman DJ, Figgie MP, Fein AW, Lee YY, Shah U, Goodman SM.

J Rheumatol. 2016 Aug;43(8):1498-502. doi: 10.3899/jrheum.151373.

PMID:
27307529
3.

Challenges for Managed Care from 340B Contract Pharmacies.

Fein AJ.

J Manag Care Spec Pharm. 2016 Mar;22(3):197-203. doi: 10.18553/jmcp.2016.22.3.197.

4.

Update in primary pulmonary lymphomas.

Cardenas-Garcia J, Talwar A, Shah R, Fein A.

Curr Opin Pulm Med. 2015 Jul;21(4):333-7. doi: 10.1097/MCP.0000000000000180. Review.

PMID:
25978630
5.

Malignant tracheal tumors: a review of current diagnostic and management strategies.

Sherani K, Vakil A, Dodhia C, Fein A.

Curr Opin Pulm Med. 2015 Jul;21(4):322-6. doi: 10.1097/MCP.0000000000000181. Review.

PMID:
25978628
6.

Wide complex tachycardia recorded with a smartphone cardiac rhythm monitor.

Waks JW, Fein AS, Das S.

JAMA Intern Med. 2015 Mar;175(3):437-9. doi: 10.1001/jamainternmed.2014.7586. No abstract available.

PMID:
25621880
7.

Invited Article: Autonomous assembly of atomically perfect nanostructures using a scanning tunneling microscope.

Celotta RJ, Balakirsky SB, Fein AP, Hess FM, Rutter GM, Stroscio JA.

Rev Sci Instrum. 2014 Dec;85(12):121301. doi: 10.1063/1.4902536.

PMID:
25554264
8.

National trends in spending on and use of oral oncologics, first quarter 2006 through third quarter 2011.

Conti RM, Fein AJ, Bhatta SS.

Health Aff (Millwood). 2014 Oct;33(10):1721-7. doi: 10.1377/hlthaff.2014.0001.

9.

Prevalence of guideline-directed medical therapy among patients receiving cardiac resynchronization therapy defibrillator implantation in the National Cardiovascular Data Registry during the years 2006 to 2008.

Schneider PM, Pellegrini CN, Wang Y, Fein AS, Reynolds MR, Curtis JP, Masoudi FA, Varosy PD.

Am J Cardiol. 2014 Jun 15;113(12):2052-6. doi: 10.1016/j.amjcard.2014.03.049.

10.

Reply: Diagnosis and treatment of obstructive sleep apnea is key to achieving optimal results after catheter ablation of atrial fibrillation.

Fein AS, Shvilkin A, Anter E.

J Am Coll Cardiol. 2014 Feb 18;63(6):608. doi: 10.1016/j.jacc.2013.10.045. No abstract available.

11.

Analyst: pharmacists have nothing to complain about.

Fein AJ.

Manag Care. 2013 Jul;22(7):14. No abstract available.

12.

Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation.

Fein AS, Shvilkin A, Shah D, Haffajee CI, Das S, Kumar K, Kramer DB, Zimetbaum PJ, Buxton AE, Josephson ME, Anter E.

J Am Coll Cardiol. 2013 Jul 23;62(4):300-5. doi: 10.1016/j.jacc.2013.03.052.

13.

NF-κB-associated mechanisms underlying the response of embryonic cells to Doxorubicin.

Savion S, Oserov G, Orenstein H, Torchinsky A, Fein A, Toder V.

Toxicol In Vitro. 2013 Mar;27(2):804-11. doi: 10.1016/j.tiv.2012.12.017.

PMID:
23274771
14.

Leadership and resuscitation: attention must be paid!-with apologies to Arthur Miller.

Fein AB.

Crit Care Med. 2012 Sep;40(9):2719-20. doi: 10.1097/CCM.0b013e31825ce8cf. No abstract available.

PMID:
22903099
15.

Prevalence and predictors of off-label use of cardiac resynchronization therapy in patients enrolled in the National Cardiovascular Data Registry Implantable Cardiac-Defibrillator Registry.

Fein AS, Wang Y, Curtis JP, Masoudi FA, Varosy PD, Reynolds MR; National Cardiovascular Data Registry..

J Am Coll Cardiol. 2010 Aug 31;56(10):766-73. doi: 10.1016/j.jacc.2010.05.025.

16.

Regional ICU care: the future is now.

Chang SY, Merwin SL, Fein J, Fein AM.

J Intensive Care Med. 2010 May-Jun;25(3):179-81. doi: 10.1177/0885066610362634. No abstract available.

PMID:
20483831
17.

Teratogen-induced alterations in microRNA-34, microRNA-125b and microRNA-155 expression: correlation with embryonic p53 genotype and limb phenotype.

Gueta K, Molotski N, Gerchikov N, Mor E, Savion S, Fein A, Toder V, Shomron N, Torchinsky A.

BMC Dev Biol. 2010 Feb 21;10:20. doi: 10.1186/1471-213X-10-20.

18.

Effect of maternal immunopotentiation on apoptosis-associated molecules expression in teratogen-treated embryos.

Savion S, Aroch I, Mammon K, Orenstein H, Fein A, Torchinsky A, Toder V.

Am J Reprod Immunol. 2009 Dec;62(6):400-11. doi: 10.1111/j.1600-0897.2009.00757.x.

PMID:
19895375
19.

Tumor necrosis factor-alpha-associated mechanisms affecting the embryonic response to cyclophosphamide.

Mammon K, Savion S, Orenstein H, Fein A, Torchinsky A, Toder V.

Am J Reprod Immunol. 2009 Sep;62(3):174-86. doi: 10.1111/j.1600-0897.2009.00727.x.

PMID:
19694643
20.

Bax-associated mechanisms underlying the response of embryonic cells to methotrexate.

Savion S, Shtelman E, Orenstein H, Torchinsky A, Fein A, Toder V.

Toxicol In Vitro. 2009 Sep;23(6):1062-8. doi: 10.1016/j.tiv.2009.06.004.

PMID:
19524032
Items per page

Supplemental Content

Support Center